We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Advanced Drug Development a Reality with UK's Most Powerful Nuclear Magnetic Resonance Facility

By LabMedica International staff writers
Posted on 30 Nov 2010
UK researchers are gaining new insights into vital high tech engineering materials and novel pharmaceuticals due to the creation of the UK's most powerful nuclear magnetic resonance (NMR) device for solids now sited in a national research facility.

The new UK 850 MHz Solid-State NMR Facility at the University of Warwick's (UK) Center for Magnetic Resonance was launched in the University's Millburn House on October 28, 2010. More...
It is a national facility open to a large range of researchers across the United Kingdom and has been made possible by the award of a GBP 3.7 million grant from the Engineering and Physical Sciences Research Council (EPSRC; Swindon, Wiltshire, UK) and the Biotechnology and Biological Sciences Research Council (BBSRC; Swindon, Wiltshire, UK).

The new facility was formally launched by David Delpy, the chief executive of EPSRC at a special event, which was attended by researchers from all the main facility partners (Universities of Warwick, Cambridge, Durham, Nottingham, Glasgow, and St. Andrews). David Delpy said, "The EPSRC are pleased to have supported the UK's internationally leading research for over 15 years. NMR spectroscopy is a vital analytical tool science. It is a powerful technique that can provide detailed information on the topology, dynamics, and three-dimensional structure of molecules in solution and the solid state.”

Prof. Mark Smith, deputy vice-chancellor of the University of Warwick, said, "This facility provides a significant leap in the capability available to the UK's NMR spectroscopy researchers that allows us to compete with the very best in the world. This was possible through the coordinated efforts of a wide range of researchers and funders and is a model of such a partnership for developing such facilities for the UK in the future. It is certain to provide us with new insights into everything from potential new pharmaceuticals to innovate materials for the next generation of catalytic convertors.”

Related Links:
University of Warwick
UK Engineering and Physical Sciences Research Council
UK Biotechnology and Biological Sciences Research Council


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Rapid Molecular Testing Device
FlashDetect Flash10
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.